Abstract
In tobacco carcinogenesis research, considerable attention has been paid to the choice of the bioassay. The ideal system should simulate the human smoking setting as closely as possible and should utilize tissue of a type similar to that found at the sites where the tobacco smoke-related cancers originate in man. However, although certain inhalation experiments in the laboratory meet these requirements to some extent, they are generally timeconsuming and difficult to evaluate and since they usually have to be performed on large animals, are extremely costly when used for the identification of the actual tumorigenic agents in the smoke.
The present article examines the reasons why mouse skin is a useful bioassay. The system has enabled investigators to identify tumour initiators and accelerators and to determine that the major tumour promoters reside in the weakly acidic portion of tobacco smoke. The mouse skin bioassay demonstrated that with significant inhibition of the pyrosynthesis of alkylated and non-alkylated polynuclear aromatic hydrocarbons, the tumorigenicity of the “tar” will also decrease significantly.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Additional information
Presented in part at the UICC Conference on Carcinogenesis by Inhalation, with Special Reference to Cigarette Smoke; Lausanne, Switzerland, June 20-22, 1969.
Rights and permissions
About this article
Cite this article
Wynder, E., Hoffmann, D. The Epidermis and the Respiratory Tract as Bioassay Systems in Tobacco Carcinogenesis. Br J Cancer 24, 574–587 (1970). https://doi.org/10.1038/bjc.1970.70
Issue Date:
DOI: https://doi.org/10.1038/bjc.1970.70
This article is cited by
-
Listen to nature. The challenge of lifestyle medicine
Sozial- und Pr�ventivmedizin SPM (1991)